Citadel Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $862K | Buy |
552,700
+79,900
| +17% | +$116K | ﹤0.01% | 8001 |
|
|
2025
Q4 | $544K | Buy |
472,800
+115,200
| +32% | +$158K | ﹤0.01% | 8830 |
|
|
2025
Q3 | $483K | Buy |
357,600
+132,300
| +59% | +$150K | ﹤0.01% | 9223 |
|
|
2025
Q2 | $213K | Buy |
225,300
+87,600
| +64% | +$56.8K | ﹤0.01% | 10542 |
|
|
2025
Q1 | $63.5K | Buy |
137,700
+104,000
| +309% | +$65.6K | ﹤0.01% | 12043 |
|
|
2024
Q4 | $24.9K | Buy |
33,700
+14,700
| +77% | +$17.7K | ﹤0.01% | 13034 |
|
|
2024
Q3 | $29.8K | Sell |
19,000
-23,700
| -56% | -$42.2K | ﹤0.01% | 12447 |
|
|
2024
Q2 | $71.7K | Sell |
42,700
-93,500
| -69% | -$168K | ﹤0.01% | 11348 |
|
|
2024
Q1 | $327K | Buy |
136,200
+97,800
| +255% | +$210K | ﹤0.01% | 9271 |
|
|
2023
Q4 | $58.8K | Buy |
38,400
+18,900
| +97% | +$22.5K | ﹤0.01% | 11612 |
|
|
2023
Q3 | $21.3K | Sell |
19,500
-900
| -4% | -$1.58K | ﹤0.01% | 12581 |
|
|
2023
Q2 | $46.7K | Sell |
20,400
-8,000
| -28% | -$21.2K | ﹤0.01% | 11880 |
|
|
2023
Q1 | $69K | Buy |
28,400
+1,200
| +4% | +$2.75K | ﹤0.01% | 11757 |
|
|
2022
Q4 | $52K | Buy |
27,200
+4,700
| +21% | +$10K | ﹤0.01% | 12086 |
|
|
2022
Q3 | $54K | Sell |
22,500
-3,600
| -14% | -$9.96K | ﹤0.01% | 11571 |
|
|
2022
Q2 | $49K | Buy |
26,100
+6,100
| +31% | +$11.6K | ﹤0.01% | 11952 |
|
|
2022
Q1 | $42K | Sell |
20,000
-14,300
| -42% | -$39.6K | ﹤0.01% | 12906 |
|
|
2021
Q4 | $135K | Sell |
34,300
-19,200
| -36% | -$93.3K | ﹤0.01% | 12395 |
|
|
2021
Q3 | $257K | Sell |
53,500
-3,800
| -7% | -$15.6K | ﹤0.01% | 11419 |
|
|
2021
Q2 | $263K | Sell |
57,300
-6,600
| -10% | -$31.8K | ﹤0.01% | 11590 |
|
|
2021
Q1 | $375K | Buy |
63,900
+27,700
| +77% | +$192K | ﹤0.01% | 10341 |
|
|
2020
Q4 | $124K | Sell |
36,200
-15,300
| -30% | -$29.2K | ﹤0.01% | 10081 |
|
|
2020
Q3 | $74K | Buy |
51,500
+32,600
| +172% | +$58K | ﹤0.01% | 9433 |
|
|
2020
Q2 | $38K | Sell |
18,900
-6,800
| -26% | -$13.3K | ﹤0.01% | 9405 |
|
|
2020
Q1 | $50K | Sell |
25,700
-6,200
| -19% | -$18.5K | ﹤0.01% | 9027 |
|
|
2019
Q4 | $132K | Buy |
31,900
+400
| +1% | +$1.54K | ﹤0.01% | 8422 |
|
|
2019
Q3 | $95K | Buy |
31,500
+3,900
| +14% | +$12.1K | ﹤0.01% | 8504 |
|
|
2019
Q2 | $174K | Sell |
27,600
-22,500
| -45% | -$135K | ﹤0.01% | 8276 |
|
|
2019
Q1 | $279K | Buy |
50,100
+19,000
| +61% | +$115K | ﹤0.01% | 7721 |
|
|
2018
Q4 | $207K | Buy |
31,100
+10,300
| +50% | +$83.4K | ﹤0.01% | 7811 |
|
|
2018
Q3 | $222K | Sell |
20,800
-26,500
| -56% | -$304K | ﹤0.01% | 8049 |
|
|
2018
Q2 | $568K | Buy |
47,300
+35,900
| +315% | +$367K | ﹤0.01% | 6156 |
|
|
2018
Q1 | $98K | Buy |
+11,400
| New | +$105K | ﹤0.01% | 7720 |
|
|
2017
Q4 | – | Sell |
-16,600
| Closed | -$204K | – | 8248 |
|
|
2017
Q3 | $204K | Buy |
16,600
+2,200
| +15% | +$32.5K | ﹤0.01% | 6666 |
|
|
2017
Q2 | $237K | Buy |
14,400
+3,000
| +26% | +$46.5K | ﹤0.01% | 6297 |
|
|
2017
Q1 | $163K | Buy |
+11,400
| New | +$169K | ﹤0.01% | 6648 |
|
|
2016
Q1 | – | Sell |
-900
| Closed | -$12K | – | 7453 |
|
|
2015
Q4 | $12K | Sell |
900
-5,600
| -86% | -$68.8K | ﹤0.01% | 8206 |
|
|
2015
Q3 | $70K | Buy |
6,500
+6,200
| +2,067% | +$67.7K | ﹤0.01% | 7304 |
|
|
2015
Q2 | $2K | Buy |
+300
| New | +$2.2K | ﹤0.01% | 8621 |
|
Other funds holding LXRX
AG
SL
SC
VCM
